1. Home
  2. QIPT vs NYXH Comparison

QIPT vs NYXH Comparison

Compare QIPT & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quipt Home Medical Corp.

QIPT

Quipt Home Medical Corp.

HOLD

Current Price

$3.65

Market Cap

161.9M

Sector

N/A

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$3.17

Market Cap

190.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QIPT
NYXH
Founded
1993
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.9M
190.6M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
QIPT
NYXH
Price
$3.65
$3.17
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$3.83
$11.67
AVG Volume (30 Days)
378.6K
56.7K
Earning Date
03-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$245,359,000.00
N/A
Revenue This Year
$28.30
$97.32
Revenue Next Year
$1.79
$241.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.37
$3.37
52 Week High
$3.65
$11.87

Technical Indicators

Market Signals
Indicator
QIPT
NYXH
Relative Strength Index (RSI) 65.72 28.09
Support Level $3.55 N/A
Resistance Level N/A $5.02
Average True Range (ATR) 0.01 0.27
MACD -0.00 -0.08
Stochastic Oscillator 80.00 1.47

Price Performance

Historical Comparison
QIPT
NYXH

About QIPT Quipt Home Medical Corp.

Quipt Home Medical Corp is a provider of durable medical equipment (DME) and home medical equipment (HME) in the United States. The Company specializes in delivering in-home treatments for the management of chronic conditions, with a primary focus on respiratory diseases, and supports patients with heart and pulmonary diseases, sleep apnea, reduced mobility, and other chronic health challenges. Its products and services include Sleep Apnea and PAP treatment, home medical equipment, home ventilation, and custom mobility solutions. The Company operates in a single business segment, comprising the sale and rental of medical equipment and related devices, and serves patients across 27 states in the United States.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: